Spinosad
- PMID: 30000810
- Bookshelf ID: NBK501751
Spinosad
Excerpt
No information is available on the clinical use of spinosad during breastfeeding. Because it is not systemically absorbed after topical application, it should not be present in breastmilk. However, the topical suspension contains benzyl alcohol, which may be systemically absorbed through the skin. High doses of benzyl alcohol are potentially toxic to neonates, but it is unlikely that doses this high reach breastmilk.[1] Any product applied to the breast should be removed from the breast with soap and water before breastfeeding to avoid direct infant exposure.
References
-
- Fernando DD, Fischer K. Spinosad topical suspension (0.9%): A new topical treatment for scabies. Expert Rev Anti Infect Ther 2022;20:1149-54. - PubMed
Publication types
LinkOut - more resources
Full Text Sources